Abstract Background: Anxiety is a condition for which current treatments are often limited by adverse events (AEs). Components of medicinal…
Abstract Rationale: Cannabis-based medicinal products (CBMPs) have been identified as novel therapeutics for generalised anxiety disorder (GAD) based on pre-clinical…
Abstract Background: The aim of the current study was to examine patterns of medical cannabis use in those using it…
Abstract The pharmacological profile of cannabigerol (CBG), which acid form constitutes the main precursor of the most abundant cannabinoids, has…
Abstract The lack of selective pharmacological tools has limited the full unraveling of G protein-coupled receptor 18 (GPR18) functions. The…
Abstract Background: In December 2018, Michigan became the 10th state to legalize marijuana for adults. Since this law took effect,…
Abstract Objectives: Using Andersen’s model of health care seeking behavior, we examined the predisposing, enabling, and need factors associated with…
Abstract Background: Cannabis use is a global public health issue associated with increased risks of developing mental health disorders, especially…
Abstract Background: Evidence for long-term effectiveness of commercial cannabis products used to treat medical symptoms is inconsistent, despite increasingly widespread…
Abstract In recent years, there has been growing evidence that cannabinoids have promising medicinal and pharmacological effects. However, the growing…